The acquisition is a strong strategic fit with Fagron’s Essentials activities and further reinforces the Group’s position in nutraceutical ingredients Fagron, the leading global player in pharmaceutical compounding, announces that…

The acquisition is a strong strategic fit with Fagron’s Essentials activities and further reinforces the Group’s position in nutraceutical ingredients

Fagron, the leading global player in pharmaceutical compounding, announces that it has completed the acquisition of Pharmavit Europe, a leading European distributor of nutraceutical raw materials based in the Netherlands.

Pharmavit Europe supplies high-quality raw materials and semi-finished products to a diversified international compounding customer base, operating in one of the fastest-growing segments of healthcare. Driven by structural trends such as preventive healthcare, healthy ageing, and lifestyle-focused nutrition, Pharmavit Europe has delivered very strong growth in recent years. The company has a long-standing track record in its commitment to maintaining best-in-class food safety and quality standards.

The acquisition is a strong strategic fit with Fagron’s Essentials activities and further reinforces the Group’s position in nutraceutical ingredients. In addition to providing increased scale, Pharmavit Europe brings complementary capabilities, including exposure to repackaging and own brands. This operating model closely aligns with Fagron’s approach and creates attractive opportunities for cross-selling and portfolio expansion across Fagron’s global footprint.

The acquisition price of the transaction is approximately €68 million. Pharmavit Europe generates annual revenues of around €62 million and currently operates with an EBITDA margin below Fagron’s group average, offering clear potential for margin improvement as the business is integrated. Fagron expects to realise synergies over the next 18 to 24 months, supported by operational excellence initiatives, procurement benefits, and commercial collaboration within the Group.